SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027214
Filing Date
2021-05-13
Accepted
2021-05-13 07:34:51
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gmtx-10q_20210331.htm 10-Q 1468767
2 EX-10.1 gmtx-ex101_158.htm EX-10.1 143674
3 EX-10.2 gmtx-ex102_159.htm EX-10.2 146733
4 EX-31.1 gmtx-ex311_9.htm EX-31.1 20056
5 EX-31.2 gmtx-ex312_8.htm EX-31.2 20036
6 EX-32.1 gmtx-ex321_7.htm EX-32.1 18626
  Complete submission text file 0001564590-21-027214.txt   5577537

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gmtx-20210331.xml EX-101.INS 899428
8 XBRL TAXONOMY EXTENSION SCHEMA gmtx-20210331.xsd EX-101.SCH 57720
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gmtx-20210331_cal.xml EX-101.CAL 36851
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gmtx-20210331_def.xml EX-101.DEF 150024
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE gmtx-20210331_lab.xml EX-101.LAB 387521
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gmtx-20210331_pre.xml EX-101.PRE 285720
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 21917223
SIC: 2834 Pharmaceutical Preparations